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Background: C3 glomerulopathy (C3GP) is characterized by deposition of complement C3 with absence/traces of
immunoglobulins in the glomeruli and categorized into dense deposit disease (DDD), C3 glomerulonephritis
(C3GN), complement factor H related protein 5(CFHR5) nephropathy etc. Collaborative efforts of pathologists,
complement biologists and nephrologists worldwide are expanding the histomorphological pattern and laboratory
findings related to C3GP. Hence, we studied point prevalence and morphological spectrum of C3GP in Indian
patients to correlate morphological patterns with standard therapies and outcome of the patients.
Methods: Retrospective analysis of renal biopsies (2007-2012,n-4565), which on immunofluorescence (IF) had C3
dominant deposits with absence or trace amount of immunoglobulin was carried out. Histopathology and
electronmicroscopy (EM) were reviewed; cases were re-classified as DDD and C3GN. Histomorphological patterns of
both groups were compared and correlated with treatment. Clinical details and follow up of patients were retrieved
from the department of nephrology.
Results: There were 31 cases (0.7%) of C3GP sub-classified as DDD (n-13) and C3GN (n-14). It was difficult to
sub-classify 4 cases since EM showed overlapping features. C3GN and DDD had distinct clinical characteristics
and disease outcome, though pathological features were overlapping. Majority of C3GP patients were males
and were in 2nd to 4th decade of life. Nephrotic syndrome in DDD and nephritic-nephrotic presentation in C3GN
patients was more common.
Hypertension and oliguria were more often observed in C3GN than DDD. Membranoproliferative pattern (MPGN) was
commonest pattern in DDD; other patterns seen were mesangial proliferative, mesangial expansive/nodular, exudative
and crescentic. C3GN also had all the above patterns, the predominant ones being MPGN and mesangial proliferative.
Limited follow-up revealed response to therapy only in C3GN (33%). Progression to ESRD was 33% in DDD and 10%
cases in C3GN.
Conclusion: C3GP comprise 0.7% of all renal biopsies. MPGN pattern was the commonest morphological pattern in
DDD whereas MPGN and mesangial proliferative pattern were equally dominant patterns in C3GN. EM of 4 cases (13%)
showed intermediate features. Evaluation of alternate complement pathway must be done in all cases to identify the
point of dysregulated alternate complement pathway and to confirm the diagnosis in ambiguous cases.
Virtual slides: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1730070964135632
Keywords: Alternate complement pathway, C3 glomerulopathy, Complement, Dense deposit disease, Nephrotic,
Nephritic* Correspondence: ritamduseja@yahoo.com
1Department of Histopathology, Post Graduate Institute of Medical Education
and Research, Chandigarh 160012, India
Full list of author information is available at the end of the article
© 2015 Viswanathan et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Viswanathan et al. Diagnostic Pathology  (2015) 10:6 Page 2 of 9Background
C3 glomerulopathy (G3GP) is a term coined for glomeru-
lar diseases characterized by accumulation of complement
C3 with absence or trace amount of immunoglobulin de-
position in the glomeruli [1]. Further sub-characterization
of C3GP into its subtypes i.e. DDD and C3GN require
LM/EM. Genetic evaluation is required for CFHR5 ne-
phropathy [2-4]. Sethi et al. conceptualised evolution of
C3GP based on their proteomic analysis of deposits in the
renal biopsies of MPGN type 1, DDD [5] and later C3GN
[6-8]. By advanced mass spectrometry techniques on
glomerular isolates, Sethi et al. [8], documented that de-
posits in DDD were composed of activated components of
the alternative pathway and lacked immunoglobulins.
They also demonstrated the presence of component of the
classic pathway in immune-complex mediated MPGN
type-1. Sethi et al. therefore, proposed a classification
driven by these findings on immunofluorescence that had
the correlation with pathogenetic pathway of the disease
under evaluation, classifying MPGN as either immuno-
globulin positive or negative [2]. During the same period
another entity C3GN was categorized which was also had
same proteomic profile as of DDD and concept of C3GP
evolved [6,8-10].
Earlier, based upon the localization of deposits by elec-
tron microscopy, primary MPGN were classified into three
types. These three were type-I (subendothelial immune-
complex type deposits), type-II (intramembranous osmio-
philic) and type-III (immune-complex type subendothelial
and subepithelial deposits) [3,9]. Type-I and III were typic-
ally immunoglobulin mediated diseases caused by the de-
position of immune complexes and related with activation
of classical complement pathway. MPGN type-II (also
known as DDD) was characterized by intramembranous
and mesangial osmiophilic electron-dense deposits on elec-
tron microscopy. In DDD, deposition of complement prod-
ucts were seen in immunofluorescence with absence or
trace amount of immunoglobulin [1,2].
Besides the immunohistology, abnormalities in alter-
nate pathway function were identified as a cause of
C3GP in complement-mediated MPGN. Several muta-
tions in alternative pathway inhibitors were documented
which were responsible for the aetiopathogenesis of
these diseases. Several autoantibodies responsible for the
activation or blockage of alternative pathway proteins
were also documented which contributed significantly to
this evolving concept [4,7,9].
Though, the concept of C3GP evolved from analysis
of mesangiocapillary pattern (MCGN), now is known to
have varied histomorphology including MPGN pattern,
crescentic or diffuse proliferative glomerulonephritis
[3,11,12].
It is important to diagnose and segregate patients of
C3GP from other glomerular diseases with similarmorphological patterns as targets for therapy are differ-
ent. Immune complex-mediated disease needs targeting
primary infection, relevant autoantibodies or clonal light
chains according to the diagnosis. In C3GP, plasmapher-
esis for removal of autoantibodies and recently use of
Ecluzimab [13], targeted against C5 component are the
only potential available targets. Variants of C3GP also
important from renal transplantation perspective as rate
of recurrence are variable with different subtypes of
C3GP [13,14]. One variant of C3GP has geographic/eth-
nic aggregation [15,16] (Cyprus).
There is no literature on C3GP from India. In present
pilot study, we evaluated all renal biopsies which had
only C3 deposition to find histological pattern of C3GP.
Our institute is a tertiary health care centre located in
north India catering largely to north Indian patients.
However, since it is fully equipped referral centre with
all the facilities including EM, we also get referred cases
of renal diseases from other states like Utter Pradesh,
Bihar, West Bengal, Assam, etc. Our patient cohort
might be representative of Indian patients in the context
of this group of renal diseases.
Methods
This study was carried out in the department of histopath-
ology, Post Graduate Institute Of Medical Education And
Research, (PGIMER) Chandigarh. Study period was of 5
years (second half of 2007 to the first half of 2012). It in-
cluded both retrospective and prospective data. The clin-
ical details retrieved from the records of the department
of nephrology, PGIMER, Chandigarh. Details of kidney bi-
opsies (LM, IF and EM reports) retrieved from the records
of the department of histopathology, PGIMER, Chandi-
garh. Starting material for this study was selected by
scrutinizing IF records and photomicrographs, cases
with only C3 deposits in the absence of immunoglobu-
lins for further analysis. Haematoxylin and eosin and
periodic acid Schiff stained slides were reviewed by two
nephropathologists to characterize the morphology,
and electron microscopic photographs reviewed for dif-
ferent morphological patterns of C3GP.
Cases with C3 deposits classified into following
morphological patterns
 MPGN - presence of endocapillary proliferation with
global duplicated basement membranes
 Mesangial proliferation - mesangial proliferation
with normal glomerular membranes
 Exudative/DPGN like - in addition to mesangioca-
pillary pattern presence of numerous polymorphs
and/or eosinophils in the glomeruli
 Mesangial expansive - includes nodular and non-
nodular mesangial expansive pattern
Viswanathan et al. Diagnostic Pathology  (2015) 10:6 Page 3 of 9 Crescentic - >50% of the total number of glomeruli
show crescents.
Number of sclerosed glomeruli were recorded. The
tubular atrophy and interstitial inflammation were re-
corded and graded on four step scale (Grade 0 – None,
Grade 1 - <33%, Grade 2 - 33-66%, Grade 3 - >66%).
Presence of interstitial foam cells, refractile thickening
and vascular changes were recorded (Grade 0 – Absent,
Grade 1 – present).
Definition
Nephrotic syndrome
Proteinuria ≥ 3.5 g/day or ≥ 1.5 g/d, serum albumin <
2.5 g/dl, edema, and hyperlipidemia with or without
hematuria (>5 RBCs/ HPF).
Nephroto-nephritic syndrome
Proteinuria ≥ 3.5 g/d or ≥ 1.5 g/d along with serum albu-
min < 2.5 g/dl, edema, hyperlipidemia with or without
hematuria (>5 RBCs/ HPF), hypertension (BP > 140/90
mm Hg) and renal dysfunction (eGFR 15-60 ml/min).
Advanced renal failure
Dialysis dependent renal failure or eGFR < 15 ml/min.
Complete remission
Reduction of proteinuria to < 0.3 g/d and with creatinine
clearance of > 60 ml/min/1.73m2 and serum albumin >
3.5gm/dl.
Partial remission
Reduction of proteinuria to 0.3–3.5 g/day, stable serum
creatinine (change in sr creatinine < 25%) or a decrease
in proteinuria >50% from baseline, and stable serum cre-
atinine (change in serum creatinine < 25%).
Steroid resistant nephrotic syndrome (SRNS)
Persistence of nephrotic syndrome despite oral prednis-
one (1 mg/kg/d) for 16 weeks.
Treatments
Patients were on follow up for a variable period ranging
from 6 months to 5 years. GFR was calculated using a
modification of diet in renal disease (MDRD) formula.
Patients with nephrotic or nephroto-nephritic syndrome
were treated with oral prednisolone (1 mg/kg) for a
period of 16 weeks in adults, and 4 weeks in children
with subsequent tapering (0.1 mg/kg/week). Patients
with crescents were treated with pulse methylpredniso-
lone (15mg/kg/day for 3 days), followed by oral prednis-
olone at 1 mg/kg for 2 months followed by tapering
(0.1mg/kg/week) along with pulse cyclophosphamide(7.5 mg/kg/pulse) for 6 week. A patient with no recovery
from dialysis at third months, fourth pulse was omitted.
Statistical methods
The statistical analysis was carried out using Statistical
package for social sciences (SPSS Inc., Chicago, IL, ver-
sion 15.0 for Windows). All quantitative variables were
assessed using measures of central location and mea-
sures of dispersion. For normally distributed data, means
were compared using student's t-test for two groups.
One-way analysis of variance (ANOVA) was used for
more than two groups. Qualitative or categorical variable
were described as frequencies and proportions. Propor-
tions were compared using the chi-square test wherever
applicable. All statistical tests were two-sided and per-
formed at a significance level of α = 0.05. This study was
approved by Institutional Review Board (IRB)/Ethics
committee-PGIMER Chandigarh (Letter No. Histopath-
ology/13/2088).
Consent
Written informed consent was obtained from the patient
for the publication of this report and any accompanying
images and blood/plasma/serum sample was also col-
lected for further serological/genetic investigations with
informed consent.
Results
C3GP comprised 0.7% (n-31) of total native renal biop-
sies in five years (4565). There were 13 cases (0.3%) of
DDD and 14 cases of C3GN (0.3%) of total native kidney
biopsies. Four cases (0.1%) had overlapping features be-
tween DDD and C3GN and could not further classified.
Patients of C3GP were mostly male in cases diagnosed
as C3GN (M: F = ~4:1) and DDD (M: F ratio - 2:1).
Within C3GP, most of the patients with DDD had neph-
rotic syndrome at presentation whereas most of the
cases of C3GN had nephroto-nephritic presentation.
Further, hypertension and oliguria at presentation was
more often seen in C3GN when compared to DDD. Dys-
lipidemia was seen only in DDD. Four patients of DDD
and two patients of C3GN had advanced renal failure at
presentation. However, these differences were not statis-
tically significant Table 1.
Glomerular pathology of C3GP
Dense deposit disease
In cases of DDD, classical MPGN pattern was the pre-
dominant pattern seen in 7 cases (58.33%). DPGN like or
exudative picture was seen in 2 cases (15.38%), non nodu-
lar mesangial expansive in another 2 and nodular mesan-
gial expansive pattern in 1 case. Four cases (30.77%) had
crescents in <50% of the total number of glomeruli, but
none showed crescentic glomerulonephritis. Refractile
Table 1 Clinical details of patients of DDD and C3GN
DDD n(%) C3GN n(%)
Age Mean ± SD(years) 25.08(±13.09) 33(±16.91)
Range(years) 12-51 14-64
Sex Male 8 11
Female 5 3
Nephrotic 7/13(53.9%) 4/14 (28.6%)










Low C3 levels 6(85.71) 0
Low C4 levels 1(14.29) 0
Viswanathan et al. Diagnostic Pathology  (2015) 10:6 Page 4 of 9membranes and material in mesangium noted in 7
cases (58.3%). Glomerular endothelial swelling seen in
30.77% of cases. The MPGN pattern was the predomin-
ant in both paediatric and adult groups. Paediatric pa-
tients had more often DPGN like/exudative lesions and
frequently had crescents when compared to adults cases
of DDD. Focal collapse noted in two cases Figures 1 and
2, Tables 2 and 3.
EM examination showed osmiophilic continuous or seg-
mental intramembranous and mesangial electron densities
in all cases. They were linear, rounded or sausages shaped
and were of variable lengths. Some capillary loops were
completely involved. Subepithelial humps of similar
osmiophilic material observed in 4 cases. One case
showed markedly thinned out basement membrane. In
addition, material with lesser electron densities as seen in
C3GN was seen in two cases with associated fibrillosis of
matrix. There were endothelial swelling in 4 cases, and
basement membrane remodelling observed in 7 cases.
Foot process effacement of podocytes and actin condensa-
tion seen in all cases Figure 2.
C3 glomerulonephritis
In cases of C3GN, both mesangial expansive and MPGN
patterns were commonly seen in 5 cases each (35.71%).
Mesangial expansive pattern included non nodular mesan-
gial expansive pattern (n-3, 21.42%) as well as nodular
mesangial expansive pattern (n-2, 14.29%) followed by
DPGN-like or exudative (n-3, 21.43%). One case (7.1%)
had crescentic glomerulonephritis whereas 4 cases
(28.57%) had crescents though amounting to < 50% of thetotal number of glomeruli. Refractile membranes and ma-
terial in mesangium noted in 7 cases (50%). Glomerular
endothelial swelling seen in 2 cases (14.29%) Table 2.
Comparing the histomorphological patterns within
C3GP, mesangial expansive and MPGN patterns were
more often seen in C3GN whereas MPGN with endoca-
pillary proliferation was more often seen in DDD. Cres-
centic glomerulonephritis was seen only in C3GN, but
the proportion of cases showing crescents was equal in
both. The percentage of cases showing DPGN like or ex-
udative pattern was nearly equal in these two groups.
Retractile membranes and refractile material in the
mesangium were seen in about half of the cases of each
of these two categories Figures 2 and 3, Table 2.
EM examination of cases showed dominant mesangial
deposits of immune complex type in all cases along with
subendothelial deposits in 12 cases. Subepithelial im-
mune complex types of humps were seen in 1 case only.
Endothelial swelling was observed in 3 cases and base-
ment membrane remodelling in 4 cases. Osmiophilic
electron densities like that seen in DDD was seen focally
in two cases. Foot process effacement of podocytes and
actin condensation was seen in all cases.Glomerular sclerosis
Variable number of sclerosed glomeruli were present
in 58.33% of cases of DDD (Zero-7, <10%-2, >50%-3, >90%-
1) and 57.14% among C3GN(Zero-6, <10%-4, >50%-
3, >90%- 1). However, it was not statistically significant.Tubulointerstitial changes
Within C3GP, tubulo-interstitial changes were more
frequent and more advanced in DDD compared to
C3GN. None of the cases of DDD had normal tubulo-
interstitium whereas about a quarter of cases of C3GN
did not show any tubulo-interstitial changes. The pres-
ence of interstitial foam cells in DDD was more than
twice compared to that seen in C3GN.Follow-up
Four (28.6%) DDD and two (15.4%) C3GN cases had ad-
vanced renal failure at presentation. The outcome of pa-
tients with DDD and C3GN is mentioned in Table 3.
None of the patients of DDD showed partial or complete
remission and four of them progressed to ESRD. Renal bi-
opsies of patients who progressed to ESRD had more than
50% sclerosed glomeruli. C3GN patients with nephrotic
presentation showed complete remission in one and
partial remission in two. One C3GN patient who had
advanced renal failure and crescentic morphology also




Figure 1 Photomicrograph shows histomorphological patterns of DDD. (a) Mild mesangial proliferation. (b) Membranoproliferative
glomerulonephritis with mesangial refractile material (Arrow). (c) Mesangial expansive pattern with mesangial nodules and basement membrane
duplication. (d) Diffuse proliferative lesion with florid exudation. (e) mesangiocapillary pattern with crescent. (a,c,d,e Periodic acid-Schiff and b
H&E X40 original).
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C3GP comprise 0.7% all native renal biopsies received
during five-year study period; DDD and C3GN were
equally represented ( 0.3% each) and 0.1% could not be
further categorized because significant overlap on elec-
tron microscopy. Majority of DDD patients were youn-
ger as compared to patients with C3GN. Among DDD,
69.23% of patients were <25 years of age and 30.77%
were in paediatric age group. The mean age at diagnosis
was 25.08 years. Prevalence of DDD among patients in
the younger group is comparable to studies by Lu et al.
[17] and Smith et al. [11] who studied mostly children
and young adults. However, Nasr et al. had only 43.8%
in paediatric or adolescent age group. In C3GN, themean age at diagnosis was 33 years with age range of
14-64 years [12]. Five patients (35.71%) were less than
25 years of age. In the study of C3GN by Sethi et al. [8],
age ranged from 8 to 73 years (mean, 42.5 years). Me-
dian age at onset was 29.9 years (range 7–70) [18] which
is comparable to the present study (Table 1).
There are difference in renal parameters at presenta-
tion in present cohort and ones from west reported in
literature. In DDD, majority (53.9%) of the patients had
nephrotic syndrome, 15.4% had nephroto-nephritic and
30.8% had advance renal failure at presentation. Mean
serum creatinine was 4.65 mg/dl and hypertension was
seen in 16.7%. In a study by Habib et al. [19], all patients





Figure 2 Photomicrographs showing immunofluorescence pattern and EM of DDD and C3GN. (a) DDD-IF with C3, coarse staining of glomerular
capillary loops and Bowmans capsule. (arrows) (b) Predominant mesangial rings with focal glomerular capillaries. (c) DDD - EM is showing glomerular
capillary intramembranous dense osmiophilic material of variable thickness. (d) Osmiophilic material in the mesangium (star), subendothelial (red arrow),
subepithelial humps (broad white arrows) (Uranyl acetate, b-2800, c-X36,00). (e) C3GN - IF Intense granular positivity in the mesangium and glomerular
membranes. (f) EM - Subendothelial (red arrow) and mesangial (black arrow) (Uranyl acetate,X10,000).
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study by Nasr et al. nephrotic syndrome was present in
33.3% of patients that is significantly less than patients
with nephrotic syndrome in present study. In their
study, mean serum creatinine was 2.2 mg/dl and renal
failure was seen in 59.4% of patients. In a study by Smith
et al. [11] patients of DDD had proteinuria in 90%,Table 2 Histomorphological patterns in glomeruli of DDD and
Sr. No Dense deposit disease
Pattern name Number of cases n(%) Paed
1 Membranoproliferative 7 (58.33%) 2 (50
2 Mesangial expansive* 3 (25%) 1 (25
3 DPGN-like or exudative 2 (16.67%) 1 (25
4 Crescentic 0
Note; *Includes nodular and non nodular mesangial expansive patterns.
**Includes 3 (21.43%) cases of non nodular and 2 (14.29%) cases of nodular mesangnephritic syndrome in 34% and hypertension in over
50%. In comparison with these two studies, patients of
DDD in the present study, more often presented with
nephrotic syndrome with proteinuria >3g and higher
serum creatinine values.
Similarly, patients with C3GN in had more often ad-
vanced renal failure and nephrotic range proteinuria asC3GN
C3GN
iatric group n(%) Adult group n(%) Number of cases n(%)
%) 5 (62.5%) 5 (35.71%)
%) 2 (25%) 5** (35.71%)
%) 1 (12.5%) 3 (21.43%)
0 0 1 (7.14%)
ial expansive patterns.
Table 3 Clinical follow-up of patients of DDD and C3GN
DDD n (%) TOTAL 13 cases C3GN n (%) TOTAL 14 cases
Nephrotic syndrome 7/13 (53.9%) 4/14 (28.6%)
No CR/PR 1 (9.05%) achieved CR
7 (100%)-SRNS 2 (18.1%) achieved PR
1 (25%) SRNS
Nephrotic-nephritic presentation 2/13 (15.4%) 8 (57.1%)
No CR/PR No CR/PR
No Progression to ESRD No Progression to ESRD
Advanced renal failure 4/13 (30.8%) 2 (14.3%)
No CR/PR 1 (50%)-Complete remission
4 (100%)-Progression to ESRD 1(50%)-Progression to ESRD





Figure 3 Photomicrograph shows Histomorphological patterns of C3GN. (a) Mild mesangial proliferation. (b) Membranoproliferative pattern
with basement membrane splitting (Arrow). (c) Mesangial expansive pattern with mesangial nodules. (d) Diffuse proliferative lesion with florid
exudation (e) Mesangiocapillary pattern with crescent (Periodic acid Schiff H&E, a-d, X40 original, e-X20 original).
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Table 4 Comparison of morphological patterns of DDD and C3GP
DDD C3GN














1 Membranoproliferative 58.33% 25% 55.6% 35.71% 80% 75% 68.42%
2 Mesangial proliferative 25% 45% 27.8% 35.71% - 25% 31.58%
3 DPGN-like or exudative 16.67% 12% 16.7% 21.43% 20% - -
4 Crescentic 0 18% 0 7.14% - - -
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drome was seen in 28.6%, nephroto-nephritic in 57.1%
and advanced renal failure in 14.3%. Proteinuria(24hr)
ranged from 1.2g to 7.2g/24 h (mean 3.98g/24 h). In a
study by Sethi et al. [8] all patients had hematuria and
proteinuria. 24hr urinary protein ranged from 0.615g to
15g/24h (mean 5.76g/24h). In their study, serum creatin-
ine at presentation ranged from 0.6 to 3.1 mg/dl (mean
1.5 mg/dl) that was lower than observations in the
present study (mean 4.19 mg/dl). Hypertension was seen
in 64.23% in the present study whereas nine out of their
twelve patients (75%) were hypertensive. In a study by
Servais et al. [18] mean proteinuria was 3.3 g/day (0.2–
9.0); nephrotic syndrome was seen in 68.42% of cases
and nephritic syndrome in 63.15%. Hypertension was
seen in 47.37%.
Histomorphologic spectrum of C3GN has expanded
over the years. In present study, the most common pat-
tern in biopsies with DDD was MPGN accounting for
over a half of the cases. Next common was mesangial
expansive pattern accounting for one-quarter of cases.
The least common pattern is that of exudative or DPGN
like pattern (16.67%). Though crescents were seen in
about one-third of cases (30.77%), none had crescentic
glomerulonephritis. In a study by Walker et al. mesan-
gial expansive pattern was the predominant pattern seen
in 45% of cases followed by MPGN pattern. Crescentic
glomerulonephritis was seen in one-fifth and. DPGN like
pattern in 12% of their cases. However, distribution of
various morphological subtypes in adults was similar toTable 5 Comparison of morphological patterns of DDD in pae
Sr. No Pattern name Paediatric group
Present study (%) Nasr et a
(%)
1 Membranoproliferative 50 28.6
2 Mesangial proliferative 25 28.6
3 DPGN-like or exudative 25 21.4
4 Crescentic 0 21.4that observed by Nasr et al. [12] in their adult patients
Tables 4 and 5.
However, when paediatric patients of DDD are com-
pared to paediatric patients of the series by Nasr et al.
[12] more number of patients in the present series had
MPGN pattern and lack crescentic DDD pattern. Fifty
percent of paediatric patients in the present study had
few crescents (less than 50%) These differences could be
due to ethnic differences or small sample size of paediat-
ric patients Tables 4 and 5.
In the present study, MPGN pattern was present in
lesser number of cases of C3GN when compared to the
series by Fakhouri et al. [6], Sethi et al. [8], and Servais
et al. [9]. DPGN like pattern was equally common (20%)
in study material when compared to Sethi et al. Mesan-
gial proliferation pattern, crescentic GN and cases with
lesser number of crescents was much more often seen in
present study when compared with Fakhouri et al. [6],
Sethi et al. [8], and Servais et al. [9] which do not ob-
serve any crescents (crescentic/-few crescents), DPGN
pattern at all Tables 4 and 5.Conclusion
In conclusion, incidence of C3GP is 0.7% of all native bi-
opsies with almost equal representation of DDD and
C3GN. Most of the cases of DDD have nephrotic presen-
tation whereas C3GN have nephroto-nephritic presenta-
tion; advanced renal failure at presentation is often seen in
DDD. Morphological spectrum revealed proliferativediatric and adult group
Adult group
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mon in C3GN whereas MPGN was the dominant pattern
in DDD. Limited follow-up revealed response to therapy
only in C3GN (one-third cases). There was a progression
to ESRD in one-third cases of DDD and only 10% cases of
C3GN. However, longer follow-up is needed to under-
stand the progression of the subcategories of C3GP. Auto-
immune/genetic work needs to do for the diagnosis
refinement of variants or cases with ambiguous findings.
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